Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease of children, the elderly, and immunocompromised individuals. Currently, there are no FDA-approved RSV vaccines. The RSV G glycoprotein is used for viral attachment to host cells and impairment of host immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuñez Castrejon, Ana M., O’Rourke, Sara M., Kauvar, Lawrence M., DuBois, Rebecca M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006937/
https://www.ncbi.nlm.nih.gov/pubmed/35266806
http://dx.doi.org/10.1128/jvi.02201-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006937/
https://www.ncbi.nlm.nih.gov/pubmed/35266806
http://dx.doi.org/10.1128/jvi.02201-21

Ejemplares similares